Antibodies against synthetic peptides react with the second Epstein-Barr virus-associated nuclear antigen.
about
BamHI E region of the Epstein-Barr virus genome encodes three transformation-associated nuclear proteins.Hyperphosphorylation of EBNA2 by Epstein-Barr virus protein kinase suppresses transactivation of the LMP1 promoter.Evidence that expression of c-fos protein in amnion cells is regulated by external signals.Restricted expression of EBV latent genes and T-lymphocyte-detected membrane antigen in Burkitt's lymphoma cells.Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infectionFour virally determined nuclear antigens are expressed in Epstein-Barr virus-transformed cellsThe expression of novel antigens from the Epstein-Barr virus large internal repeat.The analysis of EBV proteins which are antigenic in vivo.Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins.Identification of the Epstein-Barr virus terminal protein gene products in latently infected lymphocytesExpression of the Epstein-Barr virus nuclear protein 2 in rodent cells.Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP.A promoter for the highly spliced EBNA family of RNAs of Epstein-Barr virus.Mitosis-specific hyperphosphorylation of Epstein-Barr virus nuclear antigen 2 suppresses its function.An Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA5) partly encoded by the transformation-associated Bam WYH region of EBV DNA: preferential expression in lymphoblastoid cell lines.The 5' flanking region of the gene for the Epstein-Barr virus-encoded nuclear antigen 2 contains a cell type specific cis-acting regulatory element that activates transcription in transfected B-cells.The EBNA2-related resistance towards alpha interferon (IFN-alpha) in Burkitt's lymphoma cells effects induction of IFN-induced genes but not the activation of transcription factor ISGF-3.
P2860
Q33552058-BB02CB82-D9EB-4BB7-84AF-2B834A68E5D5Q33754919-8B23BFF6-726A-448C-84F3-40F805D3B56BQ33879383-1D287FB7-5AA4-4802-A686-B9ABD443FCA3Q33880494-C9D4139D-B2D2-4AA4-8FF9-2381160AAFE5Q34590358-76E37F33-D423-42A9-BC11-D8CC3AC3FB5CQ35593639-883B8B49-925A-49EF-90BD-6B94FA637918Q35981099-FFC641E8-6FBD-4CEE-A279-3029A3D72B0EQ35999054-FC084A5A-2BB4-4989-B7A1-78F74753B8F2Q36781303-B4A03F81-4003-45C6-A332-283100993066Q36807649-96A1E854-0A0A-4B7F-B848-5B6A9D2A2431Q36865083-FA0179AF-0AD0-4C2C-8485-9B2C5F2D7427Q36873046-BEE3BA29-9987-4F1A-9349-EB2F4D286E24Q36919542-A84FF4DB-2960-4D90-A466-531A641D30E1Q37009375-B06F42EE-467B-44F6-93FA-1CA00A63E50DQ37398140-F63875BA-EDA8-453C-B2DE-A235D4FD8B12Q40555242-ED6F775B-9A5B-4F59-B393-00EAD3EAFA41Q42008273-84DDEA70-987E-42F4-88D0-D89AD860C5C0
P2860
Antibodies against synthetic peptides react with the second Epstein-Barr virus-associated nuclear antigen.
description
1985 nî lūn-bûn
@nan
1985 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
Antibodies against synthetic p ...... us-associated nuclear antigen.
@ast
Antibodies against synthetic p ...... us-associated nuclear antigen.
@en
type
label
Antibodies against synthetic p ...... us-associated nuclear antigen.
@ast
Antibodies against synthetic p ...... us-associated nuclear antigen.
@en
prefLabel
Antibodies against synthetic p ...... us-associated nuclear antigen.
@ast
Antibodies against synthetic p ...... us-associated nuclear antigen.
@en
P2093
P2860
P1433
P1476
Antibodies against synthetic p ...... us-associated nuclear antigen.
@en
P2093
P2860
P304
P407
P577
1985-07-01T00:00:00Z